Physician profile
Eric T Rohe
NPI 1801455050
$1,321.60
in general payments reported to CMS, 2019-2025
9 companies · $623 in 2025
The $623 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $12.68 · 2022: $13.14 · 2024: $673 · 2025: $623.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $697 · Travel and Lodging: $599.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $696.66 |
| Travel and Lodging | $599.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $876.00 | 2024-2025 | Inspire |
| Genzyme Corporation | $164.02 | 2025 | |
| Vertex Pharmaceuticals Incorporated | $60.02 | 2025 | |
| Aerin Medical INC. | $56.51 | 2025 | |
| Depuy Synthes Sales INC. | $52.20 | 2025 | Matrixmidface, Matrixmandible |
| Regeneron Healthcare Solutions, INC. | $51.01 | 2025 | Dupixent |
| Medtronic, INC. | $25.82 | 2021-2022 | |
| Integra Lifesciences Corporation | $20.65 | 2024 | Relieva Spinplus Nav, Inspira Air, Acclarent Aera |
| Smith+Nephew, INC. | $15.37 | 2025 | Halo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Rohe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.